share_log

Jasper Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%), etc.

Jasper Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%)等

美股sec公告 ·  02/02 09:55
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息